Clincase is designed for today’s clinical trials that are challenging, complex and must meet stakeholders’ needs and regulatory requirements. That’s why Clincase’s robust platform and high customizability are appreciated all around the world.
The Clincase suite offers a developer-centric programming interface. Alongside our intuitive tools for investigators and powerful capabilities for data managers and monitors, Clincase offers a comprehensive set of functionalities to collect, process, review, and report data, while also providing rich data visualization capabilities.
Learn MoreSUBJECTS
STUDIES
COUNTRIES
Rated 4.6/5 on G2.com
We are using Clincase as our preferred EDC system since 15+ years, this says it all. We have successfully implemented eCRFs in many clinical and non-interventional studies with Clincase. Due its outstanding flexibility and impressive functional capabilities Clincase has always proven to be the right solution whether it was a 10-year observational study or a very complex phase I/II oncology clinical trial. Clients have been particularly impressed by the ease of use, and the fully integrated modules for ePRO, randomization, drug supply and risk-based monitoring support.“
Jens Knösel
Director eClinical Services
We're on the pulse of industry developments and respond pro-actively to the needs of our customers.
LATEST
Clincase’s Streamlined Study Build Process
At Clincase, we know that every successful clinical trial begins with a strong foundation. Our streamlined study build process is designed to address the complexities of clinical research while tailoring solutions to meet your unique needs. With trusted collaboration and advanced tools, we help your trial succeed from day one.
Clincase ePRO Expands Eastern European Language Support
Our commitment to patient-centric clinical trials continues with the expansion of our ePRO language support across Eastern Europe. Building on our existing support for Polish, Clincase ePRO now enables participants to navigate the entire interface—along with questionnaires, updates, and real-time study interactions—in their native languages, such as Hungarian, Bulgarian, Estonian, Georgian, Russian, Romanian, and Ukrainian. This language inclusion aims to reduce barriers and enhance patient engagement, particularly in Decentralized Clinical Trials (DCTs).
Enhancing Patient Engagement in Decentralized Trials: DMB 2024 Recap
Our E-Clinical Solutions Specialist, Veronika Brandmair, recently had the privilege of presenting at the 27th Annual French Association of Biomedical Data Management (DMB) Conference in Paris. This year’s conference brought together a vibrant community of clinical research professionals committed to enhancing patient centricity in clinical trials and exploring its impacts, changes, and challenges in clinical data management.